1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 4-bromo-a-23187 in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (4-bromo-a-23187) | Trials (4-bromo-a-23187) | Recent Studies (post-2010) (4-bromo-a-23187) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 63 | 0 | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Melder, DC; Olsen, RA; Powis, G; Schlager, JJ; Seewald, MJ | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 4-bromo-a-23187
Article | Year |
---|---|
High molecular weight dextran sulfate inhibits intracellular Ca2+ release and decreases growth factor-induced increases in intracellular free Ca2+ in Swiss 3T3 fibroblasts.
Topics: Arachidonic Acid; Arachidonic Acids; Arginine Vasopressin; Bradykinin; Calcimycin; Calcium; Cells, Cultured; Dextran Sulfate; Dextrans; Fibroblasts; Guanosine Triphosphate; Halothane; Heparin; Inositol 1,4,5-Trisphosphate; Mitogens; Molecular Weight; Platelet Activating Factor; Receptors, Cell Surface | 1989 |